PD-L2 molecules: PD-1 ligands and uses therefor

Details for Australian Patent Application No. 2001273096 (hide)

International Classifications

Event Publications

29 September 2005 Application Accepted

Published as AU-B-2001273096

13 October 2005 Corrigenda

Applications Accepted - Name Index Under the name Brigham and Women's Hospital, Dana-Farber Cancer Institute, Inc. and Genetics Institute, LLC, Application No. 2001273096, under INID (54) correct the title to read PD-L2 molecules: novel PD-1 ligands and uses therefor.

2 February 2006 Standard Patent Sealed

9 March 2006 Amendment Made

The nature of the amendment is: Amend the name of the co-patentee from Brigham and Women's Hospital to The Brigham and Women's Hospital, Inc.

28 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.